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Abstract  23 
Autographa californica multiple nucleopolyhedrovirus (AcMNPV) is a well-known virus in 24 
the Baculoviridae family. Presence of the p35 gene in the AcMNPV genome as a suppressor 25 
of the short interfering RNA (siRNA) pathway is a strong reason for the importance of the 26 
siRNA pathway in the host cellular defense. Given that, here we explored the roles of Dicer-2 27 
(Dcr2) and Argonaute 2 (Ago2) genes, key factors in the siRNA pathway in response to 28 
AcMNPV infection in Spodoptera frugiperda Sf9 cells. The results showed that the transcript 29 
levels of Dcr2 and Ago2 increased in response to AcMNPV infection particularly over 16 h 30 
post infection suggesting induction of the siRNA pathway. Reductions in the expression 31 
levels of Dcr2 and Ago2 by using specific dsRNAs in Sf9 cells modestly enhanced 32 
production of viral genomic DNA which indicated their role in the host antiviral defense. 33 
Using deep sequencing, our previous study showed a large number of small reads (siRNAs of 34 
∼20 nucleotides) from AcMNPV-infected Sf9 cells that were mapped to some of the viral 35 
genes (hot spots). Down-regulation of Dcr2 in Sf9 cells resulted in enhanced expression 36 
levels of the selected virus hotspot genes (i.e. ORF-9 and ORF-148), while the transcript 37 
levels of virus cold spots (i.e. ORF-18 and ORF-25) with no or few siRNAs mapped to them 38 
did not change.  Overexpression of AcMNPV p35 as a suppressor of RNAi and anti- 39 
apoptosis gene in Sf9 cells increased virus replication. Also, replication of mutant AcMNPV 40 
lacking the p35 gene was significantly increased in Sf9 cells with reduced transcript levels of 41 
Dcr2 and Ago2, highlighting the antiviral role of the siRNA pathway in Sf9 cells. Together, 42 
our results demonstrate that Dcr2 and Ago2 genes contribute in efficient antiviral response of 43 
Sf9 cells towards AcMNPV, and in turn, the AcMNPV p35 suppresses the siRNA pathway, 44 
besides being an antiapoptotic protein. 45 
 46 
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1. Introduction 48 
Following virus infection, different cellular immunity pathways such as JAK/STAT, Toll and 49 
RNA interference (RNAi) are activated in insects to prevent the spread of viral infection to 50 
other cells (Kingsolver et al., 2013). RNAi is well-known as an intracellular conserved 51 
mechanism that is critical in gene regulation and cell defense (Ding and Voinnet, 2007). The 52 
presence of endogenous or exogenous intracytoplasmic long double strand RNA (dsRNA) 53 
can trigger the RNAi machinery including the short interfering RNA (siRNA) or the 54 
microRNA pathway in the cell  (Ender and Meister, 2010). When a virus infects host cells 55 
and starts its transcription and replication, production of intermediate replicative dsRNA and 56 
other viral dsRNA structures triggers the siRNA machinery. Dicer2, one the most important 57 
members of the siRNA pathway, recognizes the viral dsRNA structures and cleaves them to 58 
small dsRNAs. Ago2 then selects one strand of the small dsRNA as a guide virus-derived 59 
small interfering RNA (vsiRNA). The guide vsiRNA leads the RNA induced silencing 60 
complex (RISC) to target viral RNA molecules that are complementary to the guide vsiRNA 61 
(Kingsolver et al., 2013; Lee et al., 2004; Matranga et al., 2005; Mehrabadi et al., 2015; 62 
Siomi and Siomi, 2009). 63 
The importance of siRNAs in insect antiviral response was first reported against RNA 64 
viruses. It was shown that Drosophila melanogaster flies with defects in key component of 65 
the siRNA pathway were more sensitive to infection with RNA viruses such as Drosophila C 66 
virus (DCV), cricket paralysis virus (CrPV) (van Rij et al., 2006), rhabdovirus vesicular 67 
stomatitis virus (Mueller et al., 2010), and Drosophila X virus (Zambon et al., 2006). Also, it 68 
was shown that silencing of Dcr2 and Ago2 increased the titer of O'nyong'nyong virus in 69 
Anopheles gambiae (Keene et al., 2004), Sindbis virus (SINV) in Aedes aegypti (Campbell et 70 
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al., 2008) and Rift Valley fever virus in Ae. aegypti and Culex quinquefasciatus mosquitoes 71 
(Dietrich et al., 2017). The importance of the RNAi pathway in defense against DNA viruses 72 
was also investigated. In D. melanogaster, mutant flies with defects in the siRNA pathway 73 
were more sensitive to infection with Invertebrate iridescent virus 6 (IIV-6) (Bronkhorst et 74 
al., 2012). Also, it was shown that silencing of Dcr2 in Helicoverpa armigera facilitated 75 
Helicoverpa armigera single nucleopolyhedrovirus (HaSNPV) infection (Jayachandran et al., 76 
2012). As a counter-defense, viruses have evolved different molecular strategies to escape 77 
from this potent antiviral defense. Viral suppressers of RNAi (VSR) have been evolved in 78 
some viruses to impair the host RNAi machinery. VSRs have been identified in some insect 79 
viruses including RNA and DNA viruses, for instance, B2 protein in Flock house virus (Li et 80 
al., 2002), CrPV-A1 and DCV-A1 proteins in CrPV and DCV (Nayak et al., 2010), and p35 81 
in Autographa californica multiple nucleopolyhedrovirus (AcMNPV) (Mehrabadi et al., 82 
2015) that are essential for normal infection of the viruses.  83 
Baculoviridae is a family of viruses with a double stranded circular DNA genome ranging 84 
from 80 to 200 kbp in length which only replicate in arthropods and mainly have narrow host 85 
ranges (Blissard and Rohrmann, 1990; Szewczyk et al., 2009). The most well-known virus in 86 
this family is AcMNPV, the type species of the Alphabaculovirus genus of the Baculoviridae 87 
family. Previous studies have suggested the importance of small RNAs in AcMNPV-host 88 
interactions. For example, it was shown that microRNA expression is altered in response to 89 
AcMNPV infection (Mehrabadi et al., 2013). Moreover, it was also found that  the anti- 90 
apoptotic p35 gene of AcMNPV functions as a VSR to attenuate the antiviral RNAi response 91 
of the host cells and facilitate virus replication (Mehrabadi et al., 2015). Although these 92 
studies highlighted the role of small RNAs, in particular siRNAs, as part of the cellular 93 
antiviral mechanism in Sf9 cells, the antiviral role of the siRNA pathway in Sf9 cells still 94 
remains to be functionally investigated. In this study, we investigated the response of the 95 
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siRNA key components (i.e. Dcr2 and Ago2) following AcMNPV infection. Moreover, their 96 
roles in antiviral defense were also investigated. Our results showed that the siRNA pathway 97 
was induced following virus infection and played an important role in antiviral defense by 98 
attenuating the expression of virus genes and virus replication. Understanding of networks 99 
involved in insect-virus interactions would help with the dissection of insect antiviral defense 100 
mechanisms and co-evolution of host antiviral defense and virus counter-defense. 101 
2. Methods and materials 102 
2.1 Cells and virus  103 
The Spodoptera frugiperda cell line (Sf9) was maintained in SF900-II serum-free medium 104 
(Invitrogen) as a monolayer at 27°C. AcMNPV was amplified in Sf9 cells, and budded 105 
viruses that accumulated in the medium were used for inoculations. In order to explore the 106 
effect of virus infection on expression of Dcr2 and Ago2 genes post infection, Sf9 cells were 107 
seeded in 12 well plates and infected by 500µl of AcMNPV (MOI of 5) in all experiments. 108 
2.2 Meta-analysis of small RNA deep sequencing and mapping of vsiRNAs 109 
We utilized previously reported small RNA deep sequencing data of mock and AcMNPV- 110 
infected Sf9 cells (Mehrabadi et al., 2013; Mehrabadi et al. 2015). Small RNA reads were 111 
filtered as previously described, mapped to the AcMNPV genome by using Bowtie mapping 112 
software, and visualized by using the Argo genome browser 113 
(http://www.broadinstitute.org/annotation/argo/). According to the previously reported small 114 
RNA deep sequencing data, there were hot spots and cold spots for vsiRNAs in the AcMNPV 115 
genome (Mehrabadi et al., 2015). Among the hot spots of the AcMNPV genome, ORF-9 and 116 
ORF-148 were selected, and ORF-18 and ORF-25 were also considered as cold spots for 117 
further studies.  118 
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2.3 DNA extraction and quantitative PCR (qPCR)  119 
Quantitative PCR was used to determine the levels of viral DNA accumulation in different 120 
experiments. To do this, DNA extraction was performed as described before (Glatz et al., 121 
2003) and subjected to qPCR using AcMNPV ie-1 gene. DNA concentrations were measured 122 
by a NanoDrop instrument (BioTek), and 10 ng total genomic DNA was used for each qPCR 123 
using SYBR Green Mix without ROX (Ampliqon) with a Mic real-time PCR (BMS) under the 124 
following conditions: 95 °C for 15 min, and 40 cycles of 95 °C for 10 s and 60 °C for 45 s, followed 125 
by the melting curve (68–95 °C). Primers used for qPCR are shown in Table 1. RPL27 was used 126 
for normalizing the data. Reactions from three biological replicates were repeated three times. 127 
2.4 RNA extraction and RT-qPCR  128 
Total RNA was extracted from mock and AcMNPV-infected Sf9 cells at 4, 8, 16, 24 and 48 129 
hpi using Tri-Reagent™ according to the manufacturer’s instructions (Molecular Research 130 
Center Inc.) and subsequently incubated with DNase I at 37 °C for 10 min followed by heat 131 
inactivation at 75 °C for 10 min. RNA concentrations were measured using a 132 
spectrophotometer and integrity was ensured through analysis of RNA on a 1% (w/v) agarose 133 
gel. RT-qPCR was carried out on the RNA extracted from mock and AcMNPV-infected Sf9 134 
cells. Approximately 2 µg of total RNA was used as template in a volume of 20 µl for first- 135 
strand cDNA synthesis with oligo (dT) primer. Samples were incubated at 42°C for 60 min 136 
followed by heating at 70°C for 5min. The cDNA samples were subjected to qPCR using 137 
gene-specific primers (Dcr2 and Ago2) while utilizing RPL27 as reference (Table 1). QPCR 138 
conditions were as follow: 95°C for 15min, followed by 40 cycles of 95°C for 10s, 57°C for 139 
10 s, and 72°C for 20 s, followed by the melting curve (68–95 °C). Transcript levels of four 140 
AcMNPV ORFs (ORF-9, -18, -25, and -148) were compared in mock and dsDcr2 transfected 141 
Sf9 cells at 24 hpi by RT-PCR utilizing the RPL27 gene as reference. For each experiment, 142 
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three biological replicates with three technical replicates were analyzed. 143 
2.5 RNAi 144 
We used RNAi to silence Dcr2 and Ago2 genes in Sf9 cells by specific dsRNA. The specific 145 
primers contained a T7 promoter sequences (Table 1) at their 5’ end designed for in vitro 146 
dsRNA synthesis. DsRNAs (~500 bp) were then produced and purified for each fragment 147 
using the MEGA Script kit according to the manufacturer’s instructions (Ambion). Also, 148 
dsRNA of the green fluorescent protein gene (dsGFP) was generated as control. Synthesis 149 
was confirmed by running dsRNA on an agarose gel and concentrations of dsRNAs were 150 
determined using by a nanodrop instrument. To induce RNA silencing in vitro, Sf9 cells were 151 
resuspended and ~1×103 cells added to individual wells of a 12-well plate. Once the 152 
monolayers had formed (~1 h) medium was removed and a transfection medium was added. 153 
This medium consisted of 0.5 ml SF-900II, 8 µl Cellfectin (Invitrogen), and 2 µg dsRNA 154 
either for gene of interest or GFP. Twenty four hours after, cells in each well were infected 155 
with 200 µl of AcMNPV inoculum as indicated above. The plate was then incubated at 27 °C 156 
for 48 h for analyses. 157 
2.6 Assessing the role of AcMNPV p35 gene as suppressor of RNAi and its effect on 158 
virus replication 159 
For expression of the p35 protein of AcMNPV in Sf9 cells, we used a previously constructed 160 
vector, pIZ/p35 with OpIE2 promotor (Mehrabadi et al., 2015). The pIZ/p35 vector was 161 
transfected into Sf9 cells using Cellfectin reagent (Invitrogen) according to the 162 
manufacturer's instructions. pIZ/GFP vector was used as control for transfection of Sf9 cells. 163 
Expression of p35 from the constructs was confirmed by RT-qPCR using a pair of specific 164 
primers for p35 (Table 1). Twenty-four hours after pIZ/p35 transfection, the cells were 165 
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infected with AcMNPV. The viral genomic DNA levels were quantified 24 h post infection 166 
as described earlier. To question whether the p35 effect is related to the siRNA suppression, 167 
we used a mutant AcMNPV lacking the p35 gene (∆p35AcMNPV), which has previously been 168 
characterized (Lin et al., 2010), and infected Sf9 cells that were previously transfected with 169 
either dsGFP (as control) or specific dsRNA to Dcr2 and Ago2 genes. Twenty-four hours 170 
after the mutant virus inoculation, virus replication was quantified in the cells using qPCR.  171 
   172 
3. Results 173 
3.1 Sf9 cells siRNA pathway was induced upon AcMNPV infection 174 
To assess the effect of AcMNPV infection on induction of the siRNA pathway in Sf9 cells, 175 
we analyzed the expression levels of Dcr2 and Ago2 genes at different times post infection. 176 
Replication of AcMNPV in Sf9 cells at different times post infection was confirmed by qPCR 177 
(Fig. 1A). Expression analysis by RT-qPCR showed that the transcript levels of Dcr2 178 
significantly increased at 8 hpi and reached to the maximum level at 48 hpi (Fig. 1B). Ago2 179 
expression level was significantly increased at 16 hpi and reached to the highest level at 48 180 
hpi (Fig. 1C). The results suggest that the expression response of Dcr2 was faster than that of 181 
Ago2 to viral infection (Fig. 1B, C).  182 
 183 
3.2 RNAi of Dcr2 and Ago2 genes enhanced AcMNPV replication in Sf9 cells  184 
Considering the progressive induction of Dcr2 and Ago2 expression levels following 185 
AcMNPV infection, we questioned their potential roles in the cell-virus interactions using 186 
dsRNA-mediated silencing of these genes. The expression levels of Dcr2 and Ago2 were 187 
significantly reduced after specific-dsRNA delivery into the cells as shown by RT-qPCR 188 
(Fig. 2A). Reduction in the expression of these genes modestly enhanced the replication of 189 
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AcMNPV compared to the mock and dsGFP transfected cells (Fig. 2B, C). RNAi of Ago2 190 
resulted in more than five-fold increase in AcMNPV replication, whereas Dcr2 RNAi 191 
enhanced replication of AcMNPV by two-fold (Fig. 2B, C). There was no difference in virus 192 
replication between the control and mock cells.  193 
3.3 RNAi of Dcr2 gene affects the expression level of some of the AcMNPV ORFs (hot 194 
spots) 195 
Virus-derived small interfering RNAs (vsiRNAs) from AcMNPV infected Sf9 cells have 196 
been reported previously (Mehrabadi et al. 2015). Uneven distribution of the mapped 197 
vsiRNAs on the AcMNPV genome resulted in hot spots (the viral genome regions with large 198 
number of mapped vsiRNA highlighting intensive targeting of these regions by siRNA) and 199 
cold spots (the viral genome regions with low number of mapped vsiRNA) in the AcMNPV 200 
genome. To establish the significance of the siRNA pathway in antiviral response of Sf9 201 
cells, Dcr2 gene was silenced and its effect on the expression levels of four AcMNPV ORFs 202 
was evaluated. AcMNPV ORF-9 and ORF-148 were selected as the hot spot genes, while 203 
ORF-18 and ORF-25 were selected from the cold spot genes (Fig. 3A). Our results indicated 204 
that RNAi of Dcr2 significantly increased the transcript levels of the hot spot genes (Fig. 3B, 205 
C), while the transcript levels of the cold spot genes were not affected (Fig. 3D, E). 206 
3.4 p35 enhanced replication of AcMNPV through suppression of antiviral RNAi 207 
response 208 
We already reported that the AcMNPV p35 gene acts as a suppressor of RNAi in different 209 
animal cells (Mehrabadi et al., 2015). Given that, we used pIZ/p35 to express this viral gene 210 
in Sf9 cells and evaluate its effect on AcMNPV replication in the cells. RT-qPCR result 211 
showed that p35 was highly expressed in the Sf9 cells transfected with pIZ/p35 (Fig. 4A). 212 
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Expression of p35 significantly, but moderately, enhanced AcMNPV replication in Sf9 cells 213 
as shown by qPCR (Fig. 4B). This modest effect is most likely due to the fact that AcMNPV 214 
already expresses p35, but overexpression of the protein prior to viral infection could further 215 
enhance viral replication by prompting suppression of the RNAi and apoptotic responses in 216 
the cells. Moreover, we used a mutant AcMNPV lacking the p35 gene (∆p35AcMNPV) and 217 
infected Sf9 cells that were previously transfected with either dsGFP or specific dsRNA to 218 
Dcr2 and Ago2 genes. Our results showed that specific dsRNA-mediated suppression of Dcr2 219 
and Ago2 significantly increased replication of the mutant virus in comparison to the control 220 
cells transfected with dsGFP (Fig. 4C, D).  221 
4. Discussion 222 
The small interfering RNA (siRNA) pathway is known as an effective antiviral response in 223 
insects against viruses (Blair and Olson, 2015; Bronkhorst et al., 2012; Bronkhorst and van 224 
Rij, 2014; Hussain et al., 2016; Jayachandran et al., 2012; Mehrabadi et al., 2015). Antiviral 225 
role of the siRNA pathway is evident against different RNA viruses in insects, however, the 226 
production of dsRNA, which triggers RNAi, has been demonstrated in both RNA and DNA 227 
viruses (Weber et al., 2006). Recent studies have shown the contribution of the siRNA 228 
pathway as an antiviral response against DNA viruses as well, although to a lesser extent. 229 
RNAi response against a DNA virus was reported in D. melanogaster infected with IIV6 230 
where production of siRNA from both strands of the virus genome was evident in Drosophila 231 
infected cells (Bronkhorst et al., 2012; Kemp et al., 2012). Further, the direct role of Dcr2 in 232 
antiviral response of Helicoverpa armigera cells (HzFB) against HaSNPV was also 233 
confirmed (Jayachandran et al., 2012). In the present study, we demonstrated the roles of 234 
Dcr2 and Ago2, the key components of the siRNA pathway, in antiviral immunity of Sf9 235 
cells.  236 
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Our results showed upregulation of Dcr2 and Ago2 expression levels following AcMNPV 237 
infection. Considering the important roles of these genes in the siRNA pathway, their 238 
induction in response to virus infection indicates induction of the cellular siRNA pathway. 239 
We found that the expression level of Dcr2 increased prior to Ago2 that could be in 240 
accordance to their role in the siRNA pathway in which Dcr2 functions upstream of Ago2 by 241 
cleaving dsRNA into siRNAs. The resultant siRNAs are then utilized by the RISC complex 242 
guiding Ago2 to target specific RNA molecules (Bernstein et al., 2001). Therefore, it seems 243 
that Dcr2 expression is induced upon virus infection to initiate the antiviral siRNA pathway. 244 
Consistent to our results, Dcr2 has been suggested to recognize viral dsRNA generated 245 
during replication (Bernstein et al., 2001; Lee et al., 2004; Marques et al., 2013; Soares et al., 246 
2014). Moreover, we showed that RNAi of Dcr2 and Ago2 modestly enhanced viral 247 
replication suggesting the antiviral role of these genes in Sf9 cells. The effect on virus 248 
replication was more pronounced when these genes were silenced in cells infected with p35- 249 
null AcMNPV. While these effects may not appear large, they could be sufficient to suppress 250 
the RNAi response, which may not be as strong as a response mounted against an RNA virus. 251 
Consistently, in other studies, the effect of silencing Dcr2 and Ago2 genes on replication of 252 
other DNA viruses, IIV6 (Bronkhorst et al., 2012; Kemp et al., 2012) and HaSNPV 253 
(Jayachandran et al., 2012), was found to be modest. In AcMNPV, combination of anti-RNAi 254 
and anti-apoptotic properties of p35, which are independent of each other, could provide a 255 
more potent suppressive effect on various arms of the host cellular antiviral responses. 256 
The role of Ago2 in antiviral immunity has been reported against different RNA viruses such 257 
as O'nyong'nyong virus in An. gambiae (Keene et al., 2004), dengue virus in Ae. aegypti and 258 
DCV and CrPV in D. melanogaster (van Rij et al., 2006). We also showed that RNAi of 259 
Dcr2 resulted in enhanced expression of viral hot spot genes; however, the expression levels 260 
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of cold spot genes were not changed. These results confirmed the antiviral role of the siRNA 261 
pathway through targeting transcripts of virus during the infection process. 262 
 Given the important role of Dcr2 and Ago2 in host antiviral immunity, some viruses encode 263 
suppressors of RNAi (VSRs) that interact with these proteins thereby suppressing the host 264 
siRNA pathway (Nayak et al., 2010). It was reported that the CrPV lethal and the DCV 265 
chronic infections in D. melanogaster are related to their VSRs. CrPV-1A protein interacts 266 
with Ago2, while DCV-1A interfered with Dcr2 function. Also, infected D. melanogaster 267 
with a recombinant SINV that encodes CrPV-1A showed more mortality in comparison with 268 
flies that were infected with a recombinant SINV encoding the DCV-1A VSR protein (Nayak 269 
et al., 2010). It was also demonstrated that the p35 gene of AcMNPV acts as a suppressor of 270 
the host siRNA pathway in different cells (Mehrabadi et al., 2015). To assess the effect of 271 
p35 on Sf9 antiviral response and AcMNPV replication, we overexpressed this gene in Sf9 272 
cells and found that it enhances viral replication, although this could also be partially due to 273 
anti-apoptotic function of the p35 protein (Clem, 2007). Using mutant AcMNPV lacking p35 274 
gene and dsRNA-mediated reduction of Dcr2 and Ago2 transcripts, we also showed that the 275 
siRNA pathway functions as a potent antiviral mechanism in Sf9 cells.  276 
In the present study, we provide further evidence for the contribution of the siRNA pathway 277 
in insect antiviral defense against DNA viruses. We showed that this antiviral pathway is 278 
induced in response to AcMNPV, and targets viral transcripts that may form dsRNA due to 279 
overlap of negative and positive strand transcripts or secondary structures following 280 
transcription. Silencing Dcr2 and Ago2 moderately enhanced AcMNPV replication and the 281 
transcript levels of hot spot genes. Also, the role of AcMNPV p35 gene in enhancing viral 282 
replication was further confirmed. Considering our results and taking previous reports into 283 
account, the involvement of the siRNA pathway in antiviral defense in Sf9 cells is confirmed. 284 
 285 
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Figure legends 377 
Figure 1: Induction of the siRNA pathway genes (Dicer-2 and Ago2) of Sf9 cells in 378 
response to AcMNPV infection. A) qPCR analysis of DNA from Sf9 cells at various times 379 
following AcMNPV infection revealed increases in viral genomic DNA (gDNA) over time. 380 
B) Expression of Dicer-2 increased in response to AcMNPV infection. C) The transcript 381 
levels of Ago2 intensified after AcMNPV infection. In all the experiments, DNA and RNA 382 
extractions were performed at 4, 8, 16, 24 and 48 hpi.  Asterisks indicate a significant 383 
difference between the control and the infected Sf9 cells (Brown-Forsythe test, *P < 0.05, 384 
**P < 0.01, ***P < 0.001). 385 
Figure 2: Antiviral role of the siRNA pathway (Dicer-2 and Ago2) in Sf9 cells. A ) RT- 386 
qPCR analysis confirmed silencing of Dcr2 and Ago2 genes using dsDcr2 and dsAgo2 24 and 387 
48 hours post transfection, respectively. B and C) AcMNPV genomic DNA (gDNA) 388 
replication increased after reduction in Dcr2 and Ago2 transcript levels, respectively, 389 
analyzed by qPCR on DNA samples which were extracted from the cells at 24 hpi. Rpl27 390 
gene was used as reference gene. Asterisks indicate a significant difference between the 391 
control and the infected Sf9 cells (Brown-Forsythe test, **P < 0.01, ***P < 0.001). 392 
Figure 3: Effect of Dcr-2 silencing on selected AcMNPV ORF transcript levels. A) 393 
Diagram showing mapping of small RNAs (blue small lines) from deep sequencing of 394 
AcMNPV-infected Sf9 cells to hot spot (ORF-9 and ORF-148) and cold spot (ORF-18 and 395 
ORF-25) genes in the AcMNPV genome that were selected for analysis (Mehrabadi et al., 396 
2015). White and yellow backgrounds represent the positive and negative viral strands, 397 
respectively. B-E) Sf9 cells were transfected with dsDcr2,  followed by 5 MOI AcMNPV 398 
infection and RT-qPCR analyses, which revealed increases in the transcript levels of the hot 399 
spot genes (ORF-9 and ORF-148) but not those of the cold spot genes (ORF-18 and ORF-25) 400 
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as compared with mock or dsGFP transfected Sf9 cells. Cell were collected for RNA 401 
extraction 24 h post AcMNPV infection. RPL27 was used as reference gene (Brown-Forsythe 402 
test, *P < 0.05, **P < 0.01). 403 
Figure 4: Baculovirus suppressor of RNAi (p35) enhances AcMNPV replication. A) The 404 
expression levels of p35 in Sf9 cells transfected either with pIZ/p35, or infected by 405 
AcMNPV, or both. B) The expression of p35 in Sf9 cells slightly increased replication of 406 
AcMNPV in Sf9 cells. C) RT-qPCR confirmed decline of Dicer-2 and Ago2 genes in Sf9 407 
cells treated with dsDcr2 and dsAgo2 at 24 hours post transfection relative to mock or dsGFP 408 
transfected cells before ∆-p35AcMNPV infection. D) qPCR analysis of DNA from ∆- 409 
p35AcMNPV-infected Sf9 cells transfected with dsGFP, dsDicer2 or dsAgo2 showed 410 
significant increases in the genomic DNA (gDNA) levels of AcMNPV in dsDicer2 and 411 
dsAgo2 transfected cells at 24 hpi (Brown-Forsythe test, *P < 0.05, **P < 0.01, ***P < 0.001, 412 
***P < 0.0001).   413 
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Table 1: Primer sequences used in this study.  414 
Primer  Primer sequence (5’ ̶  3’)  
Fwd./
Rev.  
Annealing 
temp (ºC) reference  
Sf_Ago2_RNAi-F  TAATACGACTCACTATAGGGGGTTATGAAATGTGGACGGG Fwd. 60 This study 
Sf _Ago2_RNAi-R TAATACGACTCACTATAGGGTTCGATGGGGAAGTAGATGC Rev. 60 This study 
Sf _Dcr2_RNAi-F TAATACGACTCACTATAGGGACAAGGCGACGACAAGACAA Fwd. 60 This study 
Sf _Dcr2_RNAi-R TAATACGACTCACTATAGGGGTACTTAGCAGGAGGCGCAG Rev. 60 This study 
Sf _Dcr2_qPCR-F AAAACTGTACGAGGCCGGAG Fwd. 60 This study 
Sf _Dcr2_qPCR-R TGCCTTGGTGCCTGGATAAG Rev. 60 This study 
Sf _Ago2_qPCR-F CCAAGCGATAAAAGGCACGG Fwd. 60 This study 
Sf _Ago2_qPCR-F AGACACGGATCGCATACACC Rev. 60 This study 
Sf _RPL27_qPCR-F  GAAGCCAGGTAAAGTGGTGCT Fwd. 60 This study 
Sf _RPL27_qPCR-R GTGTCCGTAGGGCTTGTCTG Rev. 60 This study 
ORF9-F ATGACGAATCGTAGATATGAATCTG Fwd. 60 (Mehrabadi et al., 2015) 
ORF9-R TTAAGCGCTAGATTCTGTGCGTTGT Rev. 60 (Mehrabadi et al., 2015) 
ORF18-F GGAGGCGCAGCCGTGACATGCCATA Fwd. 60 (Mehrabadi et al., 2015) 
ORF18-R CGACGACACCAACACATGATATTCG Rev. 60 (Mehrabadi et al., 2015) 
ORF25-F ATGGCAACTAAACGCAAGATTGGCG Fwd. 60 (Mehrabadi et al., 2015) 
ORF25-R GTCTTGCCGTTGGCCGGCTCCAAC Rev. 60 (Mehrabadi et al., 2015) 
ORF148-F ATGAGTTTTTTTTCAAATCTTCGCG Fwd. 60 (Mehrabadi et al., 2015) 
ORF148-R TTATCGAGGGGCCGTTGTTGGTGTG Rev. 60 (Mehrabadi et al., 2015) 
p35-mid F CAAAACCCGTTCTCATGATGTT Fwd. 60 (Mehrabadi et al., 2015) 
p35-mid R GTGAGCAAACGGCACAATAAC Rev. 60 (Mehrabadi et al., 2015) 
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Highlights 
• Small interfering RNA pathway (siRNA) induced in response to AcMNPV infection.  
• Dcr2 and Ago2 genes have antiviral roles in Sf9 cells. 
• The presence of the p35 gene of AcMNPV enhanced the viral replication through 
suppression of siRNA pathway. 
• SiRNA pathway targets the viral transcript thereby attenuating virus replication. 
 
 
